• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植中的患者血液管理——简要综述

Patient Blood Management in Liver Transplant-A Concise Review.

作者信息

Pérez-Calatayud Angel Augusto, Hofmann Axel, Pérez-Ferrer Antonio, Escorza-Molina Carla, Torres-Pérez Bettina, Zaccarias-Ezzat Jed Raful, Sanchez-Cedillo Aczel, Manuel Paez-Zayas Victor, Carrillo-Esper Raul, Görlinger Klaus

机构信息

Critical Care Division, Hospital General de México Dr. Eduardo Liceaga, Mexico City 06720, Mexico.

Faculty of Health and Medical Sciences, Discipline of Surgery, The University of Western Australia, Perth 6907, WA, Australia.

出版信息

Biomedicines. 2023 Apr 4;11(4):1093. doi: 10.3390/biomedicines11041093.

DOI:10.3390/biomedicines11041093
PMID:37189710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10135593/
Abstract

Transfusion of blood products in orthotopic liver transplantation (OLT) significantly increases post-transplant morbidity and mortality and is associated with reduced graft survival. Based on these results, an active effort to prevent and minimize blood transfusion is required. Patient blood management is a revolutionary approach defined as a patient-centered, systematic, evidence-based approach to improve patient outcomes by managing and preserving a patient's own blood while promoting patient safety and empowerment. This approach is based on three pillars of treatment: (1) detecting and correcting anemia and thrombocytopenia, (2) minimizing iatrogenic blood loss, detecting, and correcting coagulopathy, and (3) harnessing and increasing anemia tolerance. This review emphasizes the importance of the three-pillar nine-field matrix of patient blood management to improve patient outcomes in liver transplant recipients.

摘要

原位肝移植(OLT)中输血制品会显著增加移植后发病率和死亡率,并与移植物存活率降低相关。基于这些结果,需要积极努力预防并尽量减少输血。患者血液管理是一种革命性方法,被定义为以患者为中心、系统的、循证的方法,通过管理和保存患者自身血液,同时促进患者安全和自主权,来改善患者预后。这种方法基于三个治疗支柱:(1)检测并纠正贫血和血小板减少症;(2)尽量减少医源性失血,检测并纠正凝血功能障碍;(3)利用并提高贫血耐受性。本综述强调患者血液管理的三支柱九领域矩阵对于改善肝移植受者患者预后的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/7ba694837612/biomedicines-11-01093-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/ec568ff52736/biomedicines-11-01093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/e6c51964e703/biomedicines-11-01093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/7ba694837612/biomedicines-11-01093-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/ec568ff52736/biomedicines-11-01093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/e6c51964e703/biomedicines-11-01093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0427/10135593/7ba694837612/biomedicines-11-01093-g003.jpg

相似文献

1
Patient Blood Management in Liver Transplant-A Concise Review.肝移植中的患者血液管理——简要综述
Biomedicines. 2023 Apr 4;11(4):1093. doi: 10.3390/biomedicines11041093.
2
Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version).血液管理促进协会患者血液管理项目的行政和临床标准。第4版(儿科版)。
Paediatr Anaesth. 2019 Mar;29(3):231-236. doi: 10.1111/pan.13574.
3
A Global Definition of Patient Blood Management.患者血液管理全球定义。
Anesth Analg. 2022 Sep 1;135(3):476-488. doi: 10.1213/ANE.0000000000005873. Epub 2022 Feb 10.
4
malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature.肝移植后的恶性肿瘤:免疫抑制的影响——个人数据和文献回顾。
World J Gastroenterol. 2019 Sep 21;25(35):5356-5375. doi: 10.3748/wjg.v25.i35.5356.
5
Preoperative Clinical Characteristics That Identify Potential Low-Volume Transfusion Candidates Among Orthotopic Liver Transplant Patients.识别原位肝移植患者中潜在低容量输血候选者的术前临床特征。
Exp Clin Transplant. 2016 Aug;14(4):405-11.
6
Perioperative Patient Blood Management to Improve Outcomes.围手术期患者血液管理以改善结局。
Anesth Analg. 2018 Nov;127(5):1211-1220. doi: 10.1213/ANE.0000000000002549.
7
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short-term outcomes after liver transplantation-A systematic review of the literature and expert panel recommendations.肝移植术中输血管理、抗纤溶治疗、凝血监测及其对短期预后的影响——文献系统综述与专家小组建议
Clin Transplant. 2022 Oct;36(10):e14637. doi: 10.1111/ctr.14637.
8
Interventions for preventing thrombosis in solid organ transplant recipients.实体器官移植受者的血栓预防干预措施。
Cochrane Database Syst Rev. 2021 Mar 15;3(3):CD011557. doi: 10.1002/14651858.CD011557.pub2.
9
Patient blood management equals patient safety.患者血液管理等同于患者安全。
Best Pract Res Clin Anaesthesiol. 2016 Jun;30(2):159-69. doi: 10.1016/j.bpa.2016.04.008. Epub 2016 May 6.
10
Pharmacologic Strategies to Prevent Blood Loss and Transfusion in Orthotopic Liver Transplantation.原位肝移植中预防失血和输血的药理学策略。
Crit Care Nurs Q. 2016 Jul-Sep;39(3):267-80. doi: 10.1097/CNQ.0000000000000120.

引用本文的文献

1
Bleeding and thrombosis in intestinal transplantation; data from 145 consecutive adult transplants.肠道移植中的出血与血栓形成;来自145例连续成人移植的数据。
Res Pract Thromb Haemost. 2025 Jul 30;9(5):102990. doi: 10.1016/j.rpth.2025.102990. eCollection 2025 Jul.
2
Clinical Impact of Viscoelastic Testing in Liver Transplantation: A Before-and-After Study of Transfusion Needs and Outcomes.黏弹性检测在肝移植中的临床影响:输血需求与结局的前后对照研究
J Clin Med. 2025 Jul 9;14(14):4882. doi: 10.3390/jcm14144882.
3
Initiating a paediatric living donor liver transplant program in a resource-challenged environment: outcomes and lessons learned.

本文引用的文献

1
Elevated Pre- and Postoperative ROTEM™ Clot Lysis Indices Indicate Reduced Clot Retraction and Increased Mortality in Patients Undergoing Liver Transplantation.肝移植患者术前和术后ROTEM™凝血块溶解指数升高表明凝血块回缩减少且死亡率增加。
Biomedicines. 2022 Aug 15;10(8):1975. doi: 10.3390/biomedicines10081975.
2
A look into hemostatic characteristics during pediatric liver transplantation using the thromboelastometry (ROTEM ) test.探讨应用血栓弹力描记术(ROTEM)试验评估小儿肝移植术期间止血特性。
Liver Transpl. 2022 Oct;28(10):1628-1639. doi: 10.1002/lt.26463. Epub 2022 May 9.
3
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short-term outcomes after liver transplantation-A systematic review of the literature and expert panel recommendations.
在资源有限的环境中启动儿科活体供肝移植项目:成果与经验教训
Pediatr Surg Int. 2025 Jul 16;41(1):213. doi: 10.1007/s00383-025-06109-4.
4
CDSS score is favorable to ISTH score on outcomes for disseminated intravascular coagulation in patients with liver transplantation: a retrospective cohort study.在肝移植患者中,对于弥散性血管内凝血的预后,CDSS评分优于ISTH评分:一项回顾性队列研究。
Front Med (Lausanne). 2025 Apr 30;12:1514139. doi: 10.3389/fmed.2025.1514139. eCollection 2025.
5
Simultaneous Liver and Kidney Transplant in a Middle-Income Country: A Single-Center Experience.中等收入国家的肝肾联合移植:单中心经验
Ann Transplant. 2025 Apr 22;30:e947649. doi: 10.12659/AOT.947649.
6
Cytopenias in Autoimmune Liver Diseases-A Review.自身免疫性肝病中的血细胞减少症——综述
J Clin Med. 2025 Mar 4;14(5):1732. doi: 10.3390/jcm14051732.
7
The carbon footprint and energy consumption of liver transplantation.肝移植的碳足迹与能源消耗
Front Transplant. 2025 Jan 6;3:1441928. doi: 10.3389/frtra.2024.1441928. eCollection 2024.
8
Patient Blood Management Program Implementation: Comprehensive Recommendations and Practical Strategies.患者血液管理计划实施:全面建议和实用策略。
Braz J Cardiovasc Surg. 2024 Aug 2;39(5):e20240205. doi: 10.21470/1678-9741-2024-0205.
9
Efficacy and Safety of Prothrombin Complex Concentrates in Liver Transplantation: Evidence from Observational Studies.凝血酶原复合物浓缩剂在肝移植中的疗效与安全性:来自观察性研究的证据
J Clin Med. 2023 May 29;12(11):3749. doi: 10.3390/jcm12113749.
肝移植术中输血管理、抗纤溶治疗、凝血监测及其对短期预后的影响——文献系统综述与专家小组建议
Clin Transplant. 2022 Oct;36(10):e14637. doi: 10.1111/ctr.14637.
4
A Global Definition of Patient Blood Management.患者血液管理全球定义。
Anesth Analg. 2022 Sep 1;135(3):476-488. doi: 10.1213/ANE.0000000000005873. Epub 2022 Feb 10.
5
Baseline haemoglobin and thromboelastometry are predictive of red blood cell requirements and one-year mortality in liver transplantation.基线血红蛋白和血栓弹力描记术可预测肝移植患者的红细胞需求和一年死亡率。
Transfus Apher Sci. 2021 Dec;60(6):103259. doi: 10.1016/j.transci.2021.103259. Epub 2021 Aug 25.
6
A comparison of the in vitro effects of three fibrinogen concentrates on clot strength in blood samples from cardiac surgery patients.三种纤维蛋白原浓缩物在心脏手术患者血液样本中对血凝块强度的体外效果比较。
Acta Anaesthesiol Scand. 2021 Nov;65(10):1439-1446. doi: 10.1111/aas.13967. Epub 2021 Sep 1.
7
The hemostatic and thrombotic complications of liver disease.肝脏疾病的止血和血栓并发症。
Eur J Haematol. 2021 Oct;107(4):383-392. doi: 10.1111/ejh.13688. Epub 2021 Jul 29.
8
Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.血小板和红细胞输注与清髓性异基因造血细胞移植后急性移植物抗宿主病的风险。
Transplant Cell Ther. 2021 Oct;27(10):866.e1-866.e9. doi: 10.1016/j.jtct.2021.07.001. Epub 2021 Jul 10.
9
Differences in the biochemical composition of three plasma derived human fibrinogen concentrates.三种血浆源性人纤维蛋白原浓缩剂的生化组成差异。
Thromb Res. 2021 Sep;205:44-46. doi: 10.1016/j.thromres.2021.06.020. Epub 2021 Jul 6.
10
Pro-Con Debate: Fibrinogen Concentrate or Cryoprecipitate for Treatment of Acquired Hypofibrinogenemia in Cardiac Surgical Patients.正反方辩论:纤维蛋白原浓缩物与冷沉淀用于治疗心脏手术患者获得性低纤维蛋白原血症
Anesth Analg. 2021 Jul 1;133(1):19-28. doi: 10.1213/ANE.0000000000005513.